SPPL vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 24, 2026

SPPL

30.9
AI Score
VS
NIVF Wins

NIVF

39.9
AI Score

Investment Advisor Scores

SPPL

31score
Recommendation
SELL

NIVF

40score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric SPPL NIVF Winner
Forward P/E 0 0.0086 Tie
PEG Ratio 0 0 Tie
Revenue Growth 2.6% 11.9% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 30.9/100 39.9/100 NIVF
Profit Margin -70.8% 209.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

SPPL 1M: -3.7% · 3M: -47.0% NIVF 1M: -26.3% · 3M: -33.5%

Current Technical Phase

SPPL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.2 · Price: $2.06

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.8%), weak momentum, RSI 32

RSI (14): 32.2 · Price: $0.34

Fundamentals Snapshot

Metric SPPL NIVF
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — 0.0
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.2%
Operating Margin -0.9% -3.5%
EPS -0.56 328.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.